Osilodrostat 10MG tab and 5MG tab
Ended Awarded Last action
- Contract number
- 36C26021F0262
- Awardee
-
Recordati Rare Diseases Inc. UEI LL38YHW3Y9P4
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $139,229
Award facts
- Contract value 100% obligated
- $139,228.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, NJ 08833, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$88,702 | |
| Original award | $227,931 |
About this award
This federal contract award is for the delivery of OSILODROSTAT 10MG TAB and 5MG TAB to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA). The contract was awarded to Recordati Rare Diseases Inc., a foreign-owned, for-profit organization and manufacturer of goods, on March 10, 2021. The contract is a delivery order under Recordati's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, and has a firm fixed price of $139,228.97. The contract does not have a set-aside designation. Recordati Rare Diseases is a company that focuses on providing treatments for rare diseases, and has previously provided specialty pharmaceuticals like Signifor, Isturisa, Carbaglu, Cystadane, and Cystadrops to VA medical facilities across the country to treat conditions such as Cushing's disease, acromegaly, hyperammonemia, and homocystinuria. This contract award facilitates the streamlined procurement of Recordati's orphan drug offerings to serve veterans requiring treatment through VA healthcare programs nationwide.
Quick answers
Who was awarded contract 36C26021F0262?
36C26021F0262 was awarded to Recordati Rare Diseases Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 10, 2021.
How much is contract 36C26021F0262 worth?
The government has obligated $139,229 on 36C26021F0262.
Is contract 36C26021F0262 an order under another contract?
Yes. 36C26021F0262 is a delivery order under V797D40218, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26021F0262 competed?
The extent of competition for 36C26021F0262 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award